Comparison of SPECT/CT and planar MIBI in terms of operating time and cost in the surgical management of primary hyperparathyroidism

Dhave Setabutr, Kavita Vakharia, Stephen J. Nogan, George N. Kamel, Thomas Allen, Brian D. Saunders, David Goldenberg

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We conducted a retrospective study to compare operating times and costs in patients who underwent guided parathyroidectomies with either (1) technetium-99m (99mTc) multiplex ion-beam imaging (MIBI) parathyroid scintigraphy with single-photon emission computed tomography/computed tomography (SPECT/CT) fusion images or (2) sestamibi dual-phase 99mTc MIBI planar parathyroid scintigraphy alone preoperatively. Our study population was made up of the first 24 patients at our facility who had undergone SPECT/CT parathyroid imaging with technetium-99m (99mTc) MIBI and a group of 24 patients who had undergone MIBI planar imaging alone. Patient demographics, preoperative laboratory test results, operating times, and hospital charges were analyzed. We found that less operating time was required for the planar MIBI group than in the SPECT/CT group (mean: 135 vs. 158 min), although the difference was not statistically significant. Likewise, the total cost of treatment was lower in the planar MIBI group (mean: $10,035 vs. $11,592); the difference was statistically significant by one measure (p x 0.02, Wilcoxon rank sum test) but not by another (p x 0.06, Student t test). Although SPECT/CT is efficient for patients with small and difficult-to-localize adenomas, it has yet to demonstrate greater efficacy or cost-effectiveness than planar MIBI for routine parathyroidectomy in patients with primary hyperparathyroidism when an easily identifiable parathyroid adenoma is localized.

Original languageEnglish (US)
Pages (from-to)448-452
Number of pages5
JournalEar, Nose and Throat Journal
Volume94
Issue number10-11
StatePublished - Oct 1 2015

Fingerprint

Primary Hyperparathyroidism
Ions
Costs and Cost Analysis
Parathyroidectomy
Technetium
Nonparametric Statistics
Radionuclide Imaging
Hospital Charges
Parathyroid Neoplasms
Single Photon Emission Computed Tomography Computed Tomography
Health Care Costs
Adenoma
Cost-Benefit Analysis
Retrospective Studies
Demography
Students
Population

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Cite this

@article{830b478c1f544a09bbe36614f810c56c,
title = "Comparison of SPECT/CT and planar MIBI in terms of operating time and cost in the surgical management of primary hyperparathyroidism",
abstract = "We conducted a retrospective study to compare operating times and costs in patients who underwent guided parathyroidectomies with either (1) technetium-99m (99mTc) multiplex ion-beam imaging (MIBI) parathyroid scintigraphy with single-photon emission computed tomography/computed tomography (SPECT/CT) fusion images or (2) sestamibi dual-phase 99mTc MIBI planar parathyroid scintigraphy alone preoperatively. Our study population was made up of the first 24 patients at our facility who had undergone SPECT/CT parathyroid imaging with technetium-99m (99mTc) MIBI and a group of 24 patients who had undergone MIBI planar imaging alone. Patient demographics, preoperative laboratory test results, operating times, and hospital charges were analyzed. We found that less operating time was required for the planar MIBI group than in the SPECT/CT group (mean: 135 vs. 158 min), although the difference was not statistically significant. Likewise, the total cost of treatment was lower in the planar MIBI group (mean: $10,035 vs. $11,592); the difference was statistically significant by one measure (p x 0.02, Wilcoxon rank sum test) but not by another (p x 0.06, Student t test). Although SPECT/CT is efficient for patients with small and difficult-to-localize adenomas, it has yet to demonstrate greater efficacy or cost-effectiveness than planar MIBI for routine parathyroidectomy in patients with primary hyperparathyroidism when an easily identifiable parathyroid adenoma is localized.",
author = "Dhave Setabutr and Kavita Vakharia and Nogan, {Stephen J.} and Kamel, {George N.} and Thomas Allen and Saunders, {Brian D.} and David Goldenberg",
year = "2015",
month = "10",
day = "1",
language = "English (US)",
volume = "94",
pages = "448--452",
journal = "Ear, Nose and Throat Journal",
issn = "0145-5613",
publisher = "Medquest Communications LLC",
number = "10-11",

}

Comparison of SPECT/CT and planar MIBI in terms of operating time and cost in the surgical management of primary hyperparathyroidism. / Setabutr, Dhave; Vakharia, Kavita; Nogan, Stephen J.; Kamel, George N.; Allen, Thomas; Saunders, Brian D.; Goldenberg, David.

In: Ear, Nose and Throat Journal, Vol. 94, No. 10-11, 01.10.2015, p. 448-452.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparison of SPECT/CT and planar MIBI in terms of operating time and cost in the surgical management of primary hyperparathyroidism

AU - Setabutr, Dhave

AU - Vakharia, Kavita

AU - Nogan, Stephen J.

AU - Kamel, George N.

AU - Allen, Thomas

AU - Saunders, Brian D.

AU - Goldenberg, David

PY - 2015/10/1

Y1 - 2015/10/1

N2 - We conducted a retrospective study to compare operating times and costs in patients who underwent guided parathyroidectomies with either (1) technetium-99m (99mTc) multiplex ion-beam imaging (MIBI) parathyroid scintigraphy with single-photon emission computed tomography/computed tomography (SPECT/CT) fusion images or (2) sestamibi dual-phase 99mTc MIBI planar parathyroid scintigraphy alone preoperatively. Our study population was made up of the first 24 patients at our facility who had undergone SPECT/CT parathyroid imaging with technetium-99m (99mTc) MIBI and a group of 24 patients who had undergone MIBI planar imaging alone. Patient demographics, preoperative laboratory test results, operating times, and hospital charges were analyzed. We found that less operating time was required for the planar MIBI group than in the SPECT/CT group (mean: 135 vs. 158 min), although the difference was not statistically significant. Likewise, the total cost of treatment was lower in the planar MIBI group (mean: $10,035 vs. $11,592); the difference was statistically significant by one measure (p x 0.02, Wilcoxon rank sum test) but not by another (p x 0.06, Student t test). Although SPECT/CT is efficient for patients with small and difficult-to-localize adenomas, it has yet to demonstrate greater efficacy or cost-effectiveness than planar MIBI for routine parathyroidectomy in patients with primary hyperparathyroidism when an easily identifiable parathyroid adenoma is localized.

AB - We conducted a retrospective study to compare operating times and costs in patients who underwent guided parathyroidectomies with either (1) technetium-99m (99mTc) multiplex ion-beam imaging (MIBI) parathyroid scintigraphy with single-photon emission computed tomography/computed tomography (SPECT/CT) fusion images or (2) sestamibi dual-phase 99mTc MIBI planar parathyroid scintigraphy alone preoperatively. Our study population was made up of the first 24 patients at our facility who had undergone SPECT/CT parathyroid imaging with technetium-99m (99mTc) MIBI and a group of 24 patients who had undergone MIBI planar imaging alone. Patient demographics, preoperative laboratory test results, operating times, and hospital charges were analyzed. We found that less operating time was required for the planar MIBI group than in the SPECT/CT group (mean: 135 vs. 158 min), although the difference was not statistically significant. Likewise, the total cost of treatment was lower in the planar MIBI group (mean: $10,035 vs. $11,592); the difference was statistically significant by one measure (p x 0.02, Wilcoxon rank sum test) but not by another (p x 0.06, Student t test). Although SPECT/CT is efficient for patients with small and difficult-to-localize adenomas, it has yet to demonstrate greater efficacy or cost-effectiveness than planar MIBI for routine parathyroidectomy in patients with primary hyperparathyroidism when an easily identifiable parathyroid adenoma is localized.

UR - http://www.scopus.com/inward/record.url?scp=85017084654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017084654&partnerID=8YFLogxK

M3 - Article

C2 - 26535821

AN - SCOPUS:85017084654

VL - 94

SP - 448

EP - 452

JO - Ear, Nose and Throat Journal

JF - Ear, Nose and Throat Journal

SN - 0145-5613

IS - 10-11

ER -